We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




3D Doppler Ultrasound Used To Help Detect Breast Cancer

By HospiMedica International staff writers
Posted on 10 Nov 2008
Three-dimensional (3D) power Doppler ultrasound can help radiologists differentiate between malignant and benign breast masses, according to new research.

"Using 3D scans promises greater accuracy due to more consistent sampling over the entire tumor,” noted lead author, Gerald L. More...
LeCarpentier, Ph.D., assistant professor in the department of radiology at the University of Michigan (Ann Arbor, MI, USA). "Our study shows that 3D power Doppler ultrasound may be useful in the evaluation of some breast masses.”

Malignant breast masses frequently exhibit increased blood flow compared to normal tissue or benign masses. Utilizing 3D power Doppler ultrasound, radiologists were able to identify vessels with higher flow speeds, which likely indicate cancer. For the study, Dr. LeCarpentier and colleagues assessed 78 women between the ages of 26 and 70 who where scheduled for biopsy of a suspicious breast mass. Each of the women underwent a 3D Doppler ultrasound exam followed by core or excisional biopsy of the breast.

The study's findings demonstrated that 3D power Doppler ultrasound was highly accurate in identifying malignant breast tumors. When combined with age-based assessment and grayscale visual analysis, 3D Doppler scanning revealed a sensitivity of 100% in identifying cancerous tumors and a specificity of 86% in excluding benign tumors. "Using speed-weighted 3D power Doppler ultrasound, higher flow velocities in the malignant tumor-feeding vessels may be detected, whereas vessels with slower flow velocities in surrounding benign masses may be excluded,” Dr. LeCarpentier concluded.

The study's findings were published in the November 2008 issue of the journal Radiology.

Related Links:
University of Michigan


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.